Youll need to explain why you think the medication should be covered and may need support from your doctor
GLP-1 is specifically designed for individuals with a BMI greater than 30 or a BMI greater than 27 with at least one cardiometabolic risk factor, such as high blood pressure, high cholesterol, pre-diabetes, or type 2 diabetes
980,981 A Phase 3, multicenter, randomized trial (EudraCT 2012-000353-31, NCT01825512) compared the efficacy of DFX and DFP in pediatric patients with transfusion-dependent haemoglobinopathies and found that DFP was more effective and safer in controlling iron overload than DFX over a 12-month treatment period
Understanding your genetic profile helps PlexusDx clinicians select the most effective medication and dosing strategy for your individual metabolic type
Surgical options were discussed with the patient after the failure of conservative treatments and NovoSorb BTM was selected to aid the soft-tissue reconstruction